Latest common stock for PROK: $31K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (June 2026), PROK shows a common stock of $31K. That compares with $29K in the prior-year period — up 6.9% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PROK's common stock is now $31K (was $29K) — a 6.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether ProKidney is outperforming or lagging.
Tracking PROK's common stock over time shows whether ProKidney is scaling, shrinking, or reshaping that part of the business. The current reading is $31K That compares with $29K in the prior-year period — up 6.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has ProKidney's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $31K) with ownership activity and broader fundamentals.